PLTP and atherosclerosis: In contrast, we observed a clear PLTP-dose dependent reduction of plasma HDL levels in parallel to the induction of atherosclerosis and therefore we concluded that elevated plasma PLTP activity in transgenic mice is atherogenic because it decreases plasma HDL.